SEC recommends Bharat Biotech's COVAXIN for emergency use as India tests its vaccine delivery system
The recommendation for Bharat Biotech's vaccine came a day after the COVID-19 expert panel cleared the Serum Institute of India's emergency use authorisation application for the Oxford-AstraZeneca vaccine 'Covishield'
The SII, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval
Dr Reddy's asked to resubmit phase 2,3 trial application for Russia's Sputnik V COVID-19 vaccine by DCGI
Dr Reddy's trials will have to be first assessed in a small group of volunteers to study its efficacy before it can be tested on a larger population.
Infosys shares jump nearly 13% as US SEC concludes probe in whistleblower case; market cap soars by Rs 28,489 cr
Shares of Infosys on Tuesday jumped nearly 13 percent after the company said the US Securities and Exchange Commission (SEC) has concluded the investigation in the whistleblower allegations made last year, and that it does not anticipate any further action by the regulator
Infosys on Tuesday said the US Securities and Exchange Commission (SEC) has concluded the investigation in the whistleblower allegations made last year, and that it does not anticipate any further action by the regulator
Infosys row: IT major says not aware of any complaints against company other than one disclosed to bourses in October
Infosys, in a regulatory filing on Friday, said the company is aware of several reports referencing an additional securities class-action lawsuit against Infosys.
US-based Schall Law Firm has said it will file a class-action lawsuit against Infosys Ltd to recover losses suffered by investors in the wake of allegations of "unethical practices" at the Indian IT major
Infosys plans to hire another law firm to strengthen investigation into whistleblowers' allegations: Report
A whistleblower letter stating alleged financial misconduct and “unethical practice” against Infosys Chief Executive Officer Salil Parekh and chief financial officer Nilanjan Roy
Tesla chief Elon Musk says he is disconnecting from Twitter; farewell tweet receives thousands of replies as many express sadness
Tesla chief Elon Musk fired off a tweet on Friday indicating that he is disconnecting from Twitter, perhaps in favour of popular news and discussion platform Reddit
SEC said that a February tweet by Musk about Tesla’s production numbers violated the earlier settlement.
The SEC had asked US District Judge to hold Elon Musk in contempt over a 19 February tweet.
Lawyers for Tesla CEO Elon Musk will argue that he did not violate a fraud settlement with the US SEC.
The SEC said that tweet was improper because Musk did not get advance approval from Tesla.
The renewed public battle between Tesla’s chief executive and the SEC adds pressure on Musk.
The US Securities and Exchange Commission had asked the court to hold Elon Musk in contempt.
Tesla had $3.7 billion in cash and cash equivalents at the end of December.
The U.S. SEC seeks the court to hold Elon Musk in contempt of court for Tesla post on Twitter
SEC could seek a so-called bar order, removing Musk from Tesla’s board, or could ask for a lesser penalty.
US federal agencies to resume operations today as government shutdown ends, logistical delays expected
It will take US federal agencies days to dig out from weeks of unread emails and deal with other logistical issues like expired email passwords or ID badges, agency officials said. Furloughed workers were told not to read emails or answer phone calls while off duty.
Capping stent prices at Rs 35,000 is a good move by Narendra Modi govt, but will it stem corruption?
the US Food and Drug Administration (FDA) recalled at least 117 medical devices that were distributed globally after concluding that they led to serious health issues